Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nalini Bora

Concepts (240)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uveitis, Anterior
10
2019
29
3.430
 Why?
Autoimmune Diseases
11
2019
115
3.350
 Why?
Choroidal Neovascularization
17
2022
69
3.290
 Why?
Complement System Proteins
7
2014
56
2.020
 Why?
Macular Degeneration
10
2016
52
2.010
 Why?
Disease Models, Animal
22
2022
1651
1.790
 Why?
Autoantigens
5
2009
64
1.320
 Why?
Complement Activation
8
2010
43
1.310
 Why?
Uveitis
5
2009
28
1.130
 Why?
Rats, Inbred Lew
13
2019
68
1.130
 Why?
Immune Tolerance
6
2009
105
1.100
 Why?
Transforming Growth Factor beta2
5
2019
18
0.910
 Why?
Animals
41
2022
14402
0.900
 Why?
Rats
16
2019
3417
0.780
 Why?
Choroid
5
2012
26
0.740
 Why?
Geographic Atrophy
2
2016
9
0.690
 Why?
Complement Factor B
2
2011
10
0.680
 Why?
Complement Pathway, Alternative
2
2011
12
0.680
 Why?
Antigens, Surface
3
2010
55
0.670
 Why?
T-Lymphocytes, Regulatory
2
2009
85
0.670
 Why?
Eye Diseases
3
2008
35
0.670
 Why?
Recombinant Proteins
4
2019
570
0.630
 Why?
CD4-Positive T-Lymphocytes
2
2011
181
0.620
 Why?
Adiponectin
6
2022
76
0.620
 Why?
Complement Membrane Attack Complex
6
2011
22
0.600
 Why?
Eye
4
2006
36
0.590
 Why?
Collagen Type I
2
2009
97
0.570
 Why?
Antigens, Neoplasm
2
2008
170
0.520
 Why?
Reverse Transcriptase Polymerase Chain Reaction
8
2014
674
0.500
 Why?
Neovascularization, Pathologic
3
2012
168
0.500
 Why?
Ethanol
3
2008
323
0.490
 Why?
Lasers
8
2011
143
0.490
 Why?
Blotting, Western
6
2016
684
0.470
 Why?
Complement C4
2
2011
9
0.470
 Why?
Interleukin-2 Receptor alpha Subunit
2
2009
12
0.450
 Why?
Receptors, Cell Surface
2
2010
130
0.420
 Why?
Male
25
2020
27335
0.410
 Why?
Mice
16
2022
6428
0.410
 Why?
Honey
1
2011
8
0.410
 Why?
Keratitis
1
2011
17
0.400
 Why?
Adoptive Transfer
5
2011
38
0.400
 Why?
Pseudomonas Infections
1
2011
54
0.400
 Why?
Eye Infections, Bacterial
1
2011
35
0.400
 Why?
Eye Injuries
1
2011
33
0.390
 Why?
Wound Healing
2
2016
228
0.390
 Why?
Vascular Endothelial Growth Factor A
8
2016
233
0.380
 Why?
Complement Factor H
2
2010
11
0.380
 Why?
Complement C3
4
2014
32
0.380
 Why?
Down-Regulation
3
2007
388
0.380
 Why?
Mice, Inbred C57BL
11
2020
2002
0.380
 Why?
Protein Processing, Post-Translational
2
2009
183
0.380
 Why?
Models, Biological
1
2014
825
0.380
 Why?
Cell Proliferation
6
2020
1097
0.370
 Why?
Enzyme-Linked Immunosorbent Assay
5
2016
314
0.360
 Why?
Apoptosis
5
2014
1302
0.350
 Why?
Mice, Knockout
5
2016
928
0.350
 Why?
Epitopes
1
2009
89
0.350
 Why?
Complement Inactivator Proteins
2
2006
5
0.350
 Why?
Immunohistochemistry
5
2014
1090
0.320
 Why?
Wet Macular Degeneration
2
2022
15
0.320
 Why?
Cattle
4
2009
224
0.320
 Why?
Acyltransferases
2
2006
27
0.310
 Why?
Complement C3b
2
2006
8
0.300
 Why?
Retinal Pigment Epithelium
3
2016
24
0.290
 Why?
Esters
1
2006
25
0.280
 Why?
Immunity, Innate
1
2007
114
0.270
 Why?
Lipoxygenase Inhibitors
1
2005
6
0.260
 Why?
Prostaglandin-Endoperoxide Synthases
1
2005
26
0.260
 Why?
Angiogenesis Inhibitors
2
2020
203
0.260
 Why?
Cyclooxygenase Inhibitors
1
2005
44
0.260
 Why?
Fatty Acids
1
2006
175
0.260
 Why?
Nitric Oxide Synthase
1
2005
102
0.250
 Why?
Antigens, CD
2
2003
242
0.250
 Why?
Immunologic Factors
1
2006
130
0.250
 Why?
Carboxylic Ester Hydrolases
1
2003
8
0.240
 Why?
Injections, Intravenous
3
2009
148
0.240
 Why?
Mutagenesis, Site-Directed
1
2003
117
0.240
 Why?
Avian Proteins
1
2003
6
0.230
 Why?
Antigen-Presenting Cells
1
2003
25
0.230
 Why?
Blood Proteins
1
2003
100
0.220
 Why?
Polyethylene Glycols
2
2014
107
0.210
 Why?
Injections, Intraocular
2
2019
7
0.200
 Why?
Cytokines
3
2011
677
0.200
 Why?
Trabeculectomy
1
2020
10
0.190
 Why?
Myocardium
1
2003
443
0.190
 Why?
Trityl Compounds
1
2020
3
0.190
 Why?
Butyric Acid
1
2020
10
0.190
 Why?
Acetamides
1
2020
25
0.190
 Why?
Transforming Growth Factor beta
3
2006
158
0.180
 Why?
Peptide Fragments
2
2012
242
0.180
 Why?
Endotoxins
2
2011
37
0.170
 Why?
Glaucoma
1
2020
64
0.170
 Why?
Specific Pathogen-Free Organisms
2
2009
15
0.170
 Why?
Melanins
2
2011
31
0.170
 Why?
Nicotine
2
2012
205
0.170
 Why?
Immunoglobulin G
2
2011
227
0.160
 Why?
Thalidomide
1
2020
398
0.160
 Why?
RNA, Small Interfering
3
2010
253
0.160
 Why?
Pigment Epithelium of Eye
2
2010
16
0.150
 Why?
Lymph Nodes
2
2009
284
0.150
 Why?
Humans
16
2022
54304
0.140
 Why?
Gene Expression Regulation
3
2014
1064
0.140
 Why?
T-Lymphocytes
1
2019
374
0.140
 Why?
Retinal Degeneration
1
2016
16
0.140
 Why?
Chemokine CCL2
2
2016
79
0.130
 Why?
Alcohol Drinking
2
2008
259
0.130
 Why?
RNA, Messenger
3
2010
1203
0.130
 Why?
Photoreceptor Cells, Vertebrate
1
2014
4
0.130
 Why?
Amino Acid Sequence
3
2009
766
0.130
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2016
142
0.130
 Why?
Aspirin
1
2016
127
0.130
 Why?
Peptides
2
2022
276
0.120
 Why?
Follow-Up Studies
2
2011
2389
0.110
 Why?
In Situ Nick-End Labeling
2
2014
64
0.110
 Why?
Vascular Endothelial Growth Factors
1
2012
16
0.110
 Why?
Molecular Sequence Data
2
2004
980
0.110
 Why?
Receptors, Adiponectin
3
2022
14
0.100
 Why?
Proliferating Cell Nuclear Antigen
3
2022
82
0.100
 Why?
Membrane Glycoproteins
2
2003
270
0.100
 Why?
Administration, Topical
1
2011
71
0.100
 Why?
Cornea
1
2011
62
0.100
 Why?
Pseudomonas aeruginosa
1
2011
86
0.100
 Why?
Lipoproteins, LDL
1
2012
194
0.100
 Why?
Drug Carriers
1
2011
82
0.090
 Why?
Endothelium, Vascular
1
2012
288
0.090
 Why?
Fluorescent Antibody Technique
1
2010
141
0.090
 Why?
RNA
1
2011
202
0.090
 Why?
Antibodies, Monoclonal, Humanized
1
2012
240
0.090
 Why?
Autoantibodies
1
2011
135
0.090
 Why?
Lymphocyte Depletion
1
2009
12
0.090
 Why?
Microscopy, Confocal
3
2005
110
0.090
 Why?
Immunization
1
2009
95
0.090
 Why?
Cell Membrane
1
2010
279
0.090
 Why?
Lymphocyte Count
1
2008
23
0.080
 Why?
Forkhead Transcription Factors
1
2009
118
0.080
 Why?
Interleukin-2
1
2008
75
0.080
 Why?
Coculture Techniques
1
2008
159
0.080
 Why?
Caspase 8
1
2007
16
0.080
 Why?
Caspase 9
1
2007
20
0.080
 Why?
Cytochromes c
1
2007
41
0.080
 Why?
Diet
2
2016
584
0.080
 Why?
bcl-2-Associated X Protein
1
2007
73
0.080
 Why?
Cell Line
3
2020
1152
0.080
 Why?
Caspase 3
1
2007
135
0.080
 Why?
Growth Substances
1
2007
32
0.080
 Why?
Treatment Outcome
2
2011
5609
0.080
 Why?
Anterior Chamber
1
2007
10
0.070
 Why?
Complement C5
1
2006
3
0.070
 Why?
Complement C3-C5 Convertases
1
2006
3
0.070
 Why?
Oligodeoxyribonucleotides, Antisense
1
2006
4
0.070
 Why?
Receptors, Complement
1
2006
4
0.070
 Why?
Complement C1q
1
2006
11
0.070
 Why?
Antibodies, Blocking
1
2006
8
0.070
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2007
158
0.070
 Why?
Cyclin E
1
2006
6
0.070
 Why?
Macrophage-1 Antigen
1
2006
8
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2007
122
0.070
 Why?
Fluorescent Antibody Technique, Indirect
1
2006
26
0.070
 Why?
Cyclin-Dependent Kinase 2
1
2006
28
0.070
 Why?
Recombinant Fusion Proteins
1
2007
206
0.070
 Why?
Cell Adhesion Molecules
1
2006
87
0.070
 Why?
Inflammation
1
2010
679
0.070
 Why?
Chemokines
1
2006
96
0.070
 Why?
Models, Molecular
1
2007
423
0.070
 Why?
Arachidonate 5-Lipoxygenase
1
2005
4
0.070
 Why?
Collagen
1
2007
223
0.070
 Why?
Risk Factors
1
2014
3934
0.070
 Why?
Cyclooxygenase 2 Inhibitors
1
2005
20
0.070
 Why?
Cyclooxygenase 2
1
2005
49
0.070
 Why?
Injections, Subcutaneous
1
2005
58
0.060
 Why?
Nitric Oxide Synthase Type II
1
2005
83
0.060
 Why?
Guanidines
1
2005
36
0.060
 Why?
Immune Sera
1
2004
24
0.060
 Why?
Flow Cytometry
1
2007
547
0.060
 Why?
Macrophages
1
2007
404
0.060
 Why?
Fibroblast Growth Factors
1
2005
60
0.060
 Why?
Up-Regulation
1
2006
509
0.060
 Why?
Pyrazoles
1
2005
110
0.060
 Why?
Sequence Homology
1
2003
21
0.060
 Why?
COS Cells
1
2003
78
0.060
 Why?
Organ Specificity
1
2004
126
0.060
 Why?
Bruch Membrane
1
2003
1
0.060
 Why?
Sulfonamides
1
2005
146
0.060
 Why?
Hypersensitivity, Delayed
1
2003
21
0.060
 Why?
Enzyme Activation
1
2003
328
0.060
 Why?
Fluorescein-5-isothiocyanate
1
2022
11
0.060
 Why?
Interleukin-12
1
2003
37
0.060
 Why?
Disease Progression
1
2006
915
0.060
 Why?
Ophthalmic Solutions
1
2022
27
0.050
 Why?
Structure-Activity Relationship
1
2003
423
0.050
 Why?
Interleukin-10
1
2003
106
0.050
 Why?
Antibodies, Neutralizing
2
2012
76
0.050
 Why?
Cells, Cultured
3
2012
1737
0.050
 Why?
Antibodies, Monoclonal
1
2006
564
0.050
 Why?
Tetrazolium Salts
1
2020
17
0.050
 Why?
Time Factors
3
2014
3207
0.050
 Why?
Rats, Inbred BN
2
2012
21
0.050
 Why?
Mitomycin
1
2020
23
0.050
 Why?
Immunotherapy
1
2003
264
0.050
 Why?
Lidocaine
1
2020
48
0.050
 Why?
Human Umbilical Vein Endothelial Cells
1
2020
95
0.050
 Why?
Aging
1
2004
782
0.040
 Why?
Endothelial Cells
2
2012
294
0.040
 Why?
Immunoenzyme Techniques
2
2010
166
0.040
 Why?
Mutation
1
2003
1504
0.040
 Why?
Female
1
2016
28457
0.030
 Why?
Complement C1 Inhibitor Protein
1
2014
5
0.030
 Why?
Aminopeptidases
1
2014
18
0.030
 Why?
Matrix Metalloproteinase 9
1
2014
93
0.030
 Why?
Serine Endopeptidases
1
2014
57
0.030
 Why?
Bungarotoxins
1
2012
7
0.030
 Why?
Intravitreal Injections
1
2012
40
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
37
0.030
 Why?
Autophagy
1
2014
202
0.030
 Why?
Receptors, Nicotinic
1
2012
80
0.030
 Why?
Aged
2
2022
10054
0.030
 Why?
Complement C9
1
2011
4
0.030
 Why?
Oxidation-Reduction
1
2012
383
0.020
 Why?
Polymerase Chain Reaction
1
2012
531
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
474
0.020
 Why?
Vision, Ocular
1
2010
14
0.020
 Why?
Analysis of Variance
1
2012
634
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1476
0.020
 Why?
Transcriptome
1
2012
346
0.020
 Why?
Gene Expression
1
2012
664
0.020
 Why?
Protein Structure, Tertiary
1
2009
289
0.020
 Why?
Models, Animal
1
2009
254
0.020
 Why?
Immune System
1
2004
48
0.020
 Why?
Immunoblotting
1
2003
134
0.010
 Why?
Thromboplastin
1
2003
8
0.010
 Why?
Gene Library
1
2003
50
0.010
 Why?
Cell Adhesion
1
2003
171
0.010
 Why?
Adenoviridae
1
2003
58
0.010
 Why?
DNA, Complementary
1
2003
145
0.010
 Why?
Genetic Vectors
1
2003
139
0.010
 Why?
Retina
1
2003
65
0.010
 Why?
Swine
1
2003
429
0.010
 Why?
Protein Binding
1
2003
736
0.010
 Why?
Liver
1
2003
1226
0.010
 Why?
Middle Aged
1
2003
13076
0.000
 Why?
Bora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (240) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department